To further investigate if TLR9 expressed on bone marrow-derived cells was essential for NASH pathogenesis in this model, they created chimeric WT mice with TLR9-/- myeloid cells. This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatohepatitis.